266 related articles for article (PubMed ID: 19428604)
1. Inhibition of vaccinia virus replication by peptide aptamers.
Saccucci L; Crance JM; Colas P; Bickle M; Garin D; Iseni F
Antiviral Res; 2009 Jun; 82(3):134-40. PubMed ID: 19428604
[TBL] [Abstract][Full Text] [Related]
2. A small molecule screen in yeast identifies inhibitors targeting protein-protein interactions within the vaccinia virus replication complex.
Flusin O; Saccucci L; Contesto-Richefeu C; Hamdi A; Bardou C; Poyot T; Peinnequin A; Crance JM; Colas P; Iseni F
Antiviral Res; 2012 Nov; 96(2):187-95. PubMed ID: 22884885
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of hepatitis C virus RNA replicons by peptide aptamers.
Trahtenherts A; Gal-Tanamy M; Zemel R; Bachmatov L; Loewenstein S; Tur-Kaspa R; Benhar I
Antiviral Res; 2008 Mar; 77(3):195-205. PubMed ID: 18243349
[TBL] [Abstract][Full Text] [Related]
4. Origin-independent plasmid replication occurs in vaccinia virus cytoplasmic factories and requires all five known poxvirus replication factors.
De Silva FS; Moss B
Virol J; 2005 Mar; 2():23. PubMed ID: 15784143
[TBL] [Abstract][Full Text] [Related]
5. Methods for analysis of poxvirus DNA replication.
Traktman P; Boyle K
Methods Mol Biol; 2004; 269():169-86. PubMed ID: 15114016
[TBL] [Abstract][Full Text] [Related]
6. Peptide aptamers targeting the hepatitis B virus core protein: a new class of molecules with antiviral activity.
Butz K; Denk C; Fitscher B; Crnkovic-Mertens I; Ullmann A; Schröder CH; Hoppe-Seyler F
Oncogene; 2001 Oct; 20(45):6579-86. PubMed ID: 11641783
[TBL] [Abstract][Full Text] [Related]
7. The vaccinia virus DNA polymerase and its processivity factor.
Czarnecki MW; Traktman P
Virus Res; 2017 Apr; 234():193-206. PubMed ID: 28159613
[TBL] [Abstract][Full Text] [Related]
8. Correlation between shiftide activity and HIV-1 integrase inhibition by a peptide selected from a combinatorial library.
Armon-Omer A; Levin A; Hayouka Z; Butz K; Hoppe-Seyler F; Loya S; Hizi A; Friedler A; Loyter A
J Mol Biol; 2008 Feb; 376(4):971-82. PubMed ID: 18201721
[TBL] [Abstract][Full Text] [Related]
9. Bleomycin differentially inhibits picornavirus, herpesvirus and poxvirus replication in a human carcinoma cell line.
Nørskov-Lauritsen N; Ebbesen P
In Vivo; 1993; 7(6A):481-5. PubMed ID: 7514894
[TBL] [Abstract][Full Text] [Related]
10. Novobiocin inhibits vaccinia virus replication by blocking virus assembly.
Sekiguchi J; Shuman S
Virology; 1997 Aug; 235(1):129-37. PubMed ID: 9300044
[TBL] [Abstract][Full Text] [Related]
11. Specific inhibition of orthopoxvirus replication by a small interfering RNA targeting the D5R gene.
Vigne S; Germi R; Duraffour S; Larrat S; Andrei G; Snoeck R; Garin D; Crance JM
Antivir Ther; 2008; 13(3):357-68. PubMed ID: 18572748
[TBL] [Abstract][Full Text] [Related]
12. One-step selection of Vaccinia virus-binding DNA aptamers by MonoLEX.
Nitsche A; Kurth A; Dunkhorst A; Pänke O; Sielaff H; Junge W; Muth D; Scheller F; Stöcklein W; Dahmen C; Pauli G; Kage A
BMC Biotechnol; 2007 Aug; 7():48. PubMed ID: 17697378
[TBL] [Abstract][Full Text] [Related]
13. Identification of a small molecule that inhibits herpes simplex virus DNA Polymerase subunit interactions and viral replication.
Pilger BD; Cui C; Coen DM
Chem Biol; 2004 May; 11(5):647-54. PubMed ID: 15157875
[TBL] [Abstract][Full Text] [Related]
14. Identification of protein-protein interaction inhibitors targeting vaccinia virus processivity factor for development of antiviral agents.
Schormann N; Sommers CI; Prichard MN; Keith KA; Noah JW; Nuth M; Ricciardi RP; Chattopadhyay D
Antimicrob Agents Chemother; 2011 Nov; 55(11):5054-62. PubMed ID: 21844323
[TBL] [Abstract][Full Text] [Related]
15. An adenovirus-delivered peptide aptamer C1-1 targeting the core protein of hepatitis B virus inhibits viral DNA replication and production in vitro and in vivo.
Zhang W; Ke W; Wu SS; Gan L; Zhou R; Sun CY; Long QS; Jiang W; Xin HB
Peptides; 2009 Oct; 30(10):1816-21. PubMed ID: 19619601
[TBL] [Abstract][Full Text] [Related]
16. siRNA targeting vaccinia virus double-stranded RNA binding protein [E3L] exerts potent antiviral effects.
Dave RS; McGettigan JP; Qureshi T; Schnell MJ; Nunnari G; Pomerantz RJ
Virology; 2006 May; 348(2):489-97. PubMed ID: 16480752
[TBL] [Abstract][Full Text] [Related]
17. Low-resolution structure of vaccinia virus DNA replication machinery.
Sèle C; Gabel F; Gutsche I; Ivanov I; Burmeister WP; Iseni F; Tarbouriech N
J Virol; 2013 Feb; 87(3):1679-89. PubMed ID: 23175373
[TBL] [Abstract][Full Text] [Related]
18. Vaccinia virus uracil DNA glycosylase interacts with the A20 protein to form a heterodimeric processivity factor for the viral DNA polymerase.
Stanitsa ES; Arps L; Traktman P
J Biol Chem; 2006 Feb; 281(6):3439-51. PubMed ID: 16326701
[TBL] [Abstract][Full Text] [Related]
19. Modulation of Nr-13 antideath activity by peptide aptamers.
Nouvion AL; Thibaut J; Lohez OD; Venet S; Colas P; Gillet G; Lalle P
Oncogene; 2007 Feb; 26(5):701-10. PubMed ID: 16909120
[TBL] [Abstract][Full Text] [Related]
20. FK506, a secondary metabolite produced by Streptomyces, presents a novel antiviral activity against Orthopoxvirus infection in cell culture.
Reis SA; Moussatché N; Damaso CR
J Appl Microbiol; 2006 Jun; 100(6):1373-80. PubMed ID: 16696686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
